SI20325A - Psevdopolimorfne oblike 2-/2-/4-/bis(4-fluorofenil) metil/-1-piperazinil/ etoksi/ ocetne kisline dihidroklorida - Google Patents

Psevdopolimorfne oblike 2-/2-/4-/bis(4-fluorofenil) metil/-1-piperazinil/ etoksi/ ocetne kisline dihidroklorida Download PDF

Info

Publication number
SI20325A
SI20325A SI9820072A SI9820072A SI20325A SI 20325 A SI20325 A SI 20325A SI 9820072 A SI9820072 A SI 9820072A SI 9820072 A SI9820072 A SI 9820072A SI 20325 A SI20325 A SI 20325A
Authority
SI
Slovenia
Prior art keywords
methyl
bis
fluorophenyl
acetic acid
ethoxy
Prior art date
Application number
SI9820072A
Other languages
English (en)
Slovenian (sl)
Inventor
Berwaer
Bodson
Deleers
Dogimont
Fanara
Timmermans
Original Assignee
Ucb S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb S.A. filed Critical Ucb S.A.
Publication of SI20325A publication Critical patent/SI20325A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SI9820072A 1997-11-26 1998-11-26 Psevdopolimorfne oblike 2-/2-/4-/bis(4-fluorofenil) metil/-1-piperazinil/ etoksi/ ocetne kisline dihidroklorida SI20325A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97870193A EP0919550A1 (en) 1997-11-26 1997-11-26 Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
PCT/BE1998/000184 WO1999028310A1 (en) 1997-11-26 1998-11-26 Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride

Publications (1)

Publication Number Publication Date
SI20325A true SI20325A (sl) 2001-02-28

Family

ID=8231072

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9820072A SI20325A (sl) 1997-11-26 1998-11-26 Psevdopolimorfne oblike 2-/2-/4-/bis(4-fluorofenil) metil/-1-piperazinil/ etoksi/ ocetne kisline dihidroklorida

Country Status (39)

Country Link
US (2) US6262057B1 (pt)
EP (2) EP0919550A1 (pt)
JP (2) JP3996348B2 (pt)
KR (1) KR100557711B1 (pt)
CN (1) CN100406448C (pt)
AR (1) AR017676A1 (pt)
AT (1) ATE203237T1 (pt)
AU (1) AU735819B2 (pt)
BG (1) BG64155B1 (pt)
BR (1) BR9815405A (pt)
CA (1) CA2310318C (pt)
CO (1) CO4980892A1 (pt)
CZ (1) CZ295972B6 (pt)
DE (1) DE69801163T2 (pt)
DK (1) DK1034171T3 (pt)
EG (1) EG23776A (pt)
ES (1) ES2161552T3 (pt)
GC (1) GC0000094A (pt)
GR (1) GR3036702T3 (pt)
HU (1) HUP0100343A3 (pt)
ID (1) ID24964A (pt)
IL (1) IL135544A (pt)
MA (1) MA26569A1 (pt)
MY (1) MY119653A (pt)
NO (1) NO314692B1 (pt)
NZ (1) NZ504461A (pt)
PE (1) PE134899A1 (pt)
PL (1) PL190871B1 (pt)
PT (1) PT1034171E (pt)
RS (1) RS49904B (pt)
RU (1) RU2182575C2 (pt)
SI (1) SI20325A (pt)
SK (1) SK283237B6 (pt)
TN (1) TNSN98214A1 (pt)
TR (1) TR200001505T2 (pt)
TW (1) TWI225053B (pt)
UA (1) UA54568C2 (pt)
WO (1) WO1999028310A1 (pt)
ZA (1) ZA9810780B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002221854A1 (en) * 2000-12-15 2002-06-24 U C B, S.A. Use of cetirizine or efletirizine for preventing urticaria
WO2003009849A1 (en) * 2001-07-26 2003-02-06 Ucb, S.A. Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor
BRPI0312007B1 (pt) 2002-06-25 2015-04-14 Acrux Dds Pty Ltd Composição farmacêutica para administração transcutânea de testosterona ou fentanil e uso da dita composição
US20050181032A1 (en) * 2002-06-25 2005-08-18 Acrux Dds Pty Ltd. Metastable pharmaceutical compositions
EP1633359A1 (en) * 2003-05-28 2006-03-15 Ucb Farchim S.A. Use of efletirizine for treating persistent allergic rhinitis
WO2006050909A1 (en) * 2004-11-10 2006-05-18 Ucb Farchim Sa Novel forms of efletirizine dihydrochloride, processes for making them and pharmaceutical compositions including them
WO2008155777A2 (en) * 2007-06-18 2008-12-24 Cadila Healthcare Limited Process for preparing efletrizine
KR101006760B1 (ko) * 2008-07-17 2011-01-11 주식회사 진영테크 모터 순간 정전 복원 장치

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH505116A (it) * 1966-11-21 1971-03-31 Crc Ricerca Chim Metodo per l'ottenimento di derivati della piperazina
SE409706B (sv) 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
UA8337A1 (uk) * 1981-02-06 1996-03-29 Бальтес Ежен 2-[4-(дифенілметіл)-1-піперазиніл]-оцтові кислоти або їх аміди, або їх нетоксичні фармацевтично прийняті солі, що проявляють спазмолітичну і антигістамінну активність
NO155805C (no) * 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
GB8827391D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
GB8827390D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
US5625358A (en) * 1993-09-13 1997-04-29 Analog Devices, Inc. Digital phase-locked loop utilizing a high order sigma-delta modulator
BE1010094A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Nouveaux [2-(1-piperazinyl)ethoxy] methyle substitues.
BE1010095A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Procede de preparation de l'acide 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]-acetique et de ses sels.

Also Published As

Publication number Publication date
JP2001524548A (ja) 2001-12-04
AU735819B2 (en) 2001-07-19
PT1034171E (pt) 2001-11-30
PE134899A1 (es) 2000-01-11
HUP0100343A3 (en) 2001-09-28
AR017676A1 (es) 2001-09-12
MA26569A1 (fr) 2004-12-20
ES2161552T3 (es) 2001-12-01
EP1034171A1 (en) 2000-09-13
CZ20001787A3 (cs) 2000-09-13
TR200001505T2 (tr) 2000-09-21
RU2182575C2 (ru) 2002-05-20
UA54568C2 (uk) 2003-03-17
PL190871B1 (pl) 2006-02-28
KR20010032420A (ko) 2001-04-16
AU1327799A (en) 1999-06-16
PL340724A1 (en) 2001-02-26
US6335331B2 (en) 2002-01-01
CN100406448C (zh) 2008-07-30
CN1279676A (zh) 2001-01-10
ATE203237T1 (de) 2001-08-15
MY119653A (en) 2005-06-30
JP2007224042A (ja) 2007-09-06
JP3996348B2 (ja) 2007-10-24
GR3036702T3 (en) 2001-12-31
CO4980892A1 (es) 2000-11-27
SK283237B6 (sk) 2003-04-01
EG23776A (en) 2007-08-08
CA2310318A1 (en) 1999-06-10
US20010021712A1 (en) 2001-09-13
NO20002631D0 (no) 2000-05-23
BG104424A (en) 2001-01-31
WO1999028310A1 (en) 1999-06-10
DE69801163D1 (en) 2001-08-23
EP1034171B1 (en) 2001-07-18
YU31600A (sh) 2002-03-18
TWI225053B (en) 2004-12-11
IL135544A (en) 2004-02-08
NZ504461A (en) 2001-06-29
NO314692B1 (no) 2003-05-05
GC0000094A (en) 2005-06-29
HUP0100343A2 (hu) 2001-07-30
CA2310318C (en) 2003-10-21
SK5942000A3 (en) 2000-10-09
US6262057B1 (en) 2001-07-17
ZA9810780B (en) 1999-05-31
NO20002631L (no) 2000-05-23
KR100557711B1 (ko) 2006-03-07
DE69801163T2 (de) 2002-03-28
RS49904B (sr) 2008-08-07
ID24964A (id) 2000-08-31
IL135544A0 (en) 2001-05-20
EP0919550A1 (en) 1999-06-02
DK1034171T3 (da) 2001-11-05
BR9815405A (pt) 2000-10-10
TNSN98214A1 (fr) 2005-03-15
BG64155B1 (bg) 2004-02-27
CZ295972B6 (cs) 2005-12-14

Similar Documents

Publication Publication Date Title
US7439358B2 (en) Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
RU2303598C2 (ru) Полиморфные формы гидрохлорида 1-[4-(5-цианоиндол-3-ил)бутил]-4-(2-карбамоилбензофуран-5-ил)пиперазина
JP2008509953A (ja) ４−［［（７ｒ）−８−シクロペンチル−７−エチル−５，６，７，８−テトラヒドロ−５−メチル−４−６−オキソ−２−ピペリジニル］アミノ］−３−メトキシ−ｎ−（１−メチル−４−ピペリジニル）ベンズアミドの水和物及び多形、その製造方法、並びにその薬物としての使用
JP2007224042A (ja) ２−〔２−〔４−〔ビス（４−フルオロフェニル）メチル〕−１−ピペラジニル〕エトキシ〕酢酸ジヒドロクロリドの偽多形
WO2022217008A1 (en) Solid state forms of zavegepant and process for preparation thereof
US7678799B2 (en) Crystalline ziprasidone HCl and processes for preparation thereof
CN112851640B (zh) 嘧啶苯甲酰胺化合物的硫酸盐及其用途
EA020944B1 (ru) Кристаллическая форма i соли розувастатина цинка
MXPA00004826A (en) Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride
MX2008008961A (en) Trihydrochloride forms of a dihydropteridinone derivative and processes for preparation
WO2010107329A2 (en) Aripiprazole salts

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20100825